Open AccessReducing the economic burden in management of Guillain–Barre syndrome using modified plasmapheresis
Author(s) -
Rekha Ramaswamy Iyer,
Pragnesh H Shah,
Sher Sankar K Roy,
S. Suri
Publication year - 2016
Publication title -
asian journal of transfusion science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.262
H-Index - 22
eISSN - 1998-3565
pISSN - 0973-6247
DOI - 10.4103/0973-6247.187940
Subject(s) - plasmapheresis , medicine , guillain barre syndrome , apheresis , pediatrics , intensive care medicine , antibody , immunology , platelet
Guillain-Barre syndrome (GBS) is an autoimmune acute inflammatory demyelinating polyneuropathy affecting the peripheral nervous system treated with high-dose immunoglobulin, physical therapy, or plasmapheresis. Immunoglobulins are expensive and even plasmapheresis might not be affordable to patients visiting government set-ups.